These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8618278)

  • 1. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.
    Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M
    J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
    Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
    Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival].
    Fontana LO; García García F; Arcas Martínez Salas I; García Ligero J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Canteras Jordana M
    Arch Esp Urol; 2002 Sep; 55(7):792-6. PubMed ID: 12380307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival.
    Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
    Arch Esp Urol; 1998 Mar; 51(2):204-10. PubMed ID: 9586325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
    Korneev IA
    Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].
    Oikawa T; Nomura H; Kinsui H; Hamano S; Suzuki N; Tanaka M; Murakami S; Nokubi M; Suzuki Y
    Hinyokika Kiyo; 2001 Apr; 47(4):237-40. PubMed ID: 11411096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
    Holmäng S; Lele SM; Johansson SL
    J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inverted transitional-cell papilloma: the expression of the Ki-67 nuclear antigen as a prognostic factor].
    Valero Puerta JA; Redondo Martínez E; Jieménez González C; Gómez Medina ML; Martínez de la Riva SI
    Arch Esp Urol; 1995 Nov; 48(9):887-92. PubMed ID: 8554393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas].
    Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA
    Urologiia; 2004; (3):10-4. PubMed ID: 15199806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinicopathological study on carcinoma of the renal pelvis and ureter].
    Hashimoto H; Saga Y; Tokumitsu M; Yamaguchi S; Morikawa M; Yachiku S
    Hinyokika Kiyo; 1997 Oct; 43(10):707-12. PubMed ID: 9395905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
    Masuda M; Takano Y; Iki M; Makiyama K; Noguchi S; Hosaka M
    J Urol; 1999 Mar; 161(3):805-8; discussion 808-9. PubMed ID: 10022688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personal and histopathological factors as prognostic variables in upper urothelial tumors undergoing surgery].
    García García F; Fontana Compiano LO; García Ligero J; Arcas Martínez-Salas I; Martínez F; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Morga Egea JP; Canteras Jordana M
    Arch Esp Urol; 2002 Jun; 55(5):503-8. PubMed ID: 12174416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
    Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
    BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.